Daiichi Sankyo Company, Limited (DSKYF)
OTCMKTS
· Delayed Price · Currency is USD
17.84
-0.33 (-1.82%)
At close: Mar 6, 2026
Daiichi Sankyo Company Employees
Daiichi Sankyo Company had 19,765 employees as of March 31, 2025. The number of employees increased by 1,039 or 5.55% compared to the previous year.
Employees
19,765
Change (1Y)
1,039
Growth (1Y)
5.55%
Revenue / Employee
$662,215
Profits / Employee
$98,292
Market Cap
33.61B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Glass House Brands | 374 |
| Elite Pharmaceuticals | 68 |
| American Oncology Network | 1,914 |
| Northwest Biotherapeutics | 25 |
| CytoDyn | 13 |
| Silence Therapeutics | 116 |
| Tian'an Technology Group | 8 |
| Vaxart | 105 |
Daiichi Sankyo Company News
- 2 days ago - GAIA and Daiichi Sankyo Europe Enter Exclusive Partnership to Launch Next-Generation Digital Therapeutic for Cardiovascular Care in Europe. - Business Wire
- 12 days ago - SylamoreBio Announces Research Collaboration With Daiichi Sankyo to Advance SyLEC™ Delivery Technology - Business Wire
- 16 days ago - Daiichi Sankyo Appoints John Tsai, MD as Global Head of R&D - Business Wire
- 18 days ago - BostonGene Announces Strategic Collaboration with Daiichi Sankyo to Accelerate Drug Development Through AI-Driven Multimodal Analytics - Business Wire
- 4 weeks ago - DS3790 Enters Clinical Development as First DXd ADC in Hematology from Industry-Leading ADC Portfolio of Daiichi Sankyo - Business Wire
- 6 weeks ago - Daiichi Sankyo Appoints New Leadership at the Daiichi Sankyo Translational Research Center Europe - Business Wire
- 6 weeks ago - Daiichi Sankyo Unveils New Toronto Headquarters to Accelerate Investment and Innovation in Oncology - PRNewsWire
- 2 months ago - Organon Enters into a Commercialization Agreement for Daiichi Sankyo's Nilemdo® in France, Denmark, Iceland, Sweden, Finland and Norway - Business Wire